Basic Information
| LncRNA/CircRNA Name | SNHG3 |
| Synonyms | SNHG3, NCRNA00014, RNU17C, RNU17D, U17HG, U17HG-A, U17HG-AB |
| Region | GRCh38_1:28505980-28510892 |
| Ensemble | ENSG00000242125 |
| Refseq | NR_002909.1 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | hepatocellular carcinoma |
| ICD-0-3 | C22.0 |
| Methods | RNA-seq, qPCR, ISH etc. |
| Sample | HCC tissues |
| Expression Pattern | up-regulated |
| Function Description | Our results showed that the expression level of SNHG3 was significantly upregulated in HCC tissues compared with paired noncancerous tissues from 51 HCC patients, increased SNHG3 expression is associated with malignant status and poor prognosis in HCC patients. |
| Pubmed ID | 26373735 |
| Year | 2015 |
| Title | SNHG3 correlates with malignant status and poor prognosis in hepatocellular carcinoma. |
External Links
| Links for SNHG3 | GenBank HGNC NONCODE |
| Links for hepatocellular carcinoma | OMIM COSMIC |